Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06281977 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm

Study acronym: SEDATE
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 1 to 2v6
  2. Re-verified, no change to tracked fieldsv5
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v4
  4. Primary completion date: Mar 12, 2027 to May 8, 2027
    • Study completion date: Jul 1, 2027 to Aug 1, 2027
    • Start date: Apr 15, 2024 to May 8, 2024
    v3
  5. Start date: Mar 12, 2024 to Apr 15, 2024v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to determine if there is a meaningful benefit to using the sedative medication dexmedetomidine in the acute treatment of patients with recurrent ventricular arrhythmias, known as electrical storm. This will be a multi-centre, double-blinded, placebo-controlled, randomized trial. Patients with electrical storm will be randomized to receive 48 to 72 hours of dexmedetomidine or placebo as part of their initial treatment in an intensive care unit.
Trial Details
NCT Number NCT06281977
Lead Sponsor Ottawa Heart Institute Research Corporation
Conditions
(from sponsor)		 Ventricular Tachycardia, Ventricular Arrhythmias, Ventricular Fibrillation, Recurrent Ventricular Tachycardia
Related terms Tachycardia, Ventricular, Ventricular Fibrillation
Enrollment 192 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov